Plasma membrane transporters of serotonin, dopamine, and norepinephrine mediate serotonin accumulation in atypical locations in the developing brain of monoamine oxidase A knock-outs
Details
Download: 6914.full.pdf (1082.26 [Ko])
State: Public
Version: Final published version
State: Public
Version: Final published version
Serval ID
serval:BIB_AB1ABFD40F4E
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
Plasma membrane transporters of serotonin, dopamine, and norepinephrine mediate serotonin accumulation in atypical locations in the developing brain of monoamine oxidase A knock-outs
Journal
Journal of Neuroscience
ISSN
0270-6474 (Print)
Publication state
Published
Issued date
09/1998
Volume
18
Number
17
Pages
6914-27
Notes
Journal Article
Research Support, Non-U.S. Gov't --- Old month value: Sep 1
Research Support, Non-U.S. Gov't --- Old month value: Sep 1
Abstract
Genetic loss or pharmacological inhibition of monoamine oxidase A (MAOA) in mice leads to a large increase in whole-brain levels of serotonin (5-HT). Excess 5-HT in mouse neonates prevents the normal barrel-like clustering of thalamic axons in the somatosensory cortex. Projection fields of other neuron populations may develop abnormally. In the present study, we have analyzed the localization of 5-HT immunolabeling in the developing brain of MAOA knock-out mice. We show numerous atypical locations of 5-HT during embryonic and postnatal development. Catecholaminergic cells of the substantia nigra, ventral tegmental area, hypothalamus, and locus ceruleus display transient 5-HT immunoreactivity. Pharmacological treatments inhibiting specific monoamine plasma membrane transporters and genetic crosses with mice lacking the dopamine plasma membrane transporter show that the accumulation of 5-HT in these catecholaminergic cells is attributable to 5-HT uptake via the dopamine or the norepinephrine plasma membrane transporter. In the telencephalon, transient 5-HT immunolabeling is observed in neurons in the CA1 and CA3 fields of the hippocampus, the central amygdala, the indusium griseum, and the deep layers of the anterior cingulate and retrosplenial cortices. In the diencephalon, primary sensory nuclei, as well as the mediodorsal, centrolateral, oval paracentral, submedial, posterior, and lateral posterior thalamic nuclei, are transiently 5-HT immunolabeled. The cortical projections of these thalamic nuclei are also labeled. In the brainstem, neurons in the lateral superior olivary nucleus and the anteroventral cochlear nucleus are transiently 5-HT immunolabeled. None of these structures appear to express the monoamine biosynthetic enzyme L-aromatic amino acid decarboxylase. The administration of monoamine plasma membrane transporter inhibitors indicates that the 5-HT immunolabeling in these structures is attributable to an uptake of 5-HT by the 5-HT plasma membrane transporter. This points to neuron populations that form highly precise projection maps that could be affected by 5-HT during specific developmental stages.
Keywords
Animals
Brain/embryology/growth & development/*metabolism
Carrier Proteins
Dopamine/metabolism
Dopamine Plasma Membrane Transport Proteins
Embryonic and Fetal Development/physiology
Membrane Glycoproteins/*metabolism
*Membrane Transport Proteins
Mice
Mice, Inbred CBA
Mice, Knockout
Monoamine Oxidase/*genetics
Nerve Tissue Proteins/*metabolism
Neurons/metabolism
Norepinephrine/metabolism
Norepinephrine Plasma Membrane Transport Proteins
Serotonin/*metabolism
Serotonin Plasma Membrane Transport Proteins
*Symporters
Pubmed
Web of science
Create date
24/01/2008 14:27
Last modification date
20/08/2019 15:15